Medtronic (NYSE:MDT) announced that it entered into a memorandum of understanding with Asan Medical Center in Seoul, Korea.

Medtronic said Wednesday it has agreed to buy SPR Therapeutics, a company making a device that uses peripheral nerve ...

Medtronic will acquire SPR Therapeutics for $650 million, adding the FDA-cleared SPRINT PNS System for temporary PNS to its ...

Kweli Thompson will be promoted to head of Medtronic’s neuroscience portfolio, and Peter Menziuso will join BD’s ...

Medtronic Neurovascular announced that its Onyx Liquid Embolic System (LES), Onyx 18 and Onyx 34, received FDA approval for a shake ...

Miles Lewis had his first seizure at 4 years old. He was diagnosed with epilepsy after those seizures kept happening He was put on medication, but eventually a team of doctors at Johns Hopkins All ...

Medtronic is overhauling its cardiovascular business in a major restructuring that includes new operating divisions, ongoing acquisitions, and a strategic push into higher-growth cardiac technologies.